← FDA DRUG APPROVALS

FDA ANDA · ANDA070495

TRIMETHOPRIM

Sponsor: SUN PHARM INDUSTRIES

APPLICATION
ANDA070495
TYPE
ANDA
ORIGINAL APPROVAL
1986-03-14
LATEST ACTION
2015-10-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

TRIMETHOPRIMDiscontinued
TRIMETHOPRIM 200MG · TABLET · ORAL

Approval history

2015-10-30Labeling · Supplement 13 · standardAP
1998-12-01Manufacturing (CMC) · Supplement 12AP
1997-02-26Labeling · Supplement 11AP
1994-12-23Manufacturing (CMC) · Supplement 10AP
1994-10-11Manufacturing (CMC) · Supplement 9AP
1992-04-03Manufacturing (CMC) · Supplement 8AP
1992-04-03Manufacturing (CMC) · Supplement 6AP
1987-03-31Manufacturing (CMC) · Supplement 3AP
1986-09-05Manufacturing (CMC) · Supplement 1AP
1986-09-05Manufacturing (CMC) · Supplement 2AP
1986-03-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →